You are here » Home » Company » Natco Pharma Ltd

Natco Pharma Ltd.

BSE: 524816 Sector: Health care
NSE: NATCOPHARM ISIN Code: INE987B01026
BSE 00:00 | 20 Jun 822.45 -9.65
(-1.16%)
OPEN

835.10

HIGH

841.70

LOW

816.00

NSE 00:00 | 20 Jun 821.80 -8.60
(-1.04%)
OPEN

827.00

HIGH

841.60

LOW

816.55

OPEN 835.10
PREVIOUS CLOSE 832.10
VOLUME 10069
52-Week high 1061.95
52-Week low 671.25
P/E 21.73
Mkt Cap.(Rs cr) 15,174
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 835.10
CLOSE 832.10
VOLUME 10069
52-Week high 1061.95
52-Week low 671.25
P/E 21.73
Mkt Cap.(Rs cr) 15,174
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

About Natco Pharma Ltd.

Natco Pharma Ltd

Incorporated in Sep.'81 as Natco Fine Pharmaceutical Ltd, it became a deemed public company with effect from Jul.'92 and in Feb.'93, it changed its name to Natco Pharma (NPL). NPL began to manufacture conventional and time-release dosage forms of life-saving drugs. NPL is a contract manufacturer for reputed companies like Ranbaxy and Parke Davis. It has also obtained the coveted ISO 9002 certifica...> More

Natco Pharma Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   15,174
EPS - TTM () [*S] 37.84
P/E Ratio (X) [*S] 21.73
Face Value ()   2
Latest Dividend (%)   350.00
Latest Dividend Date 15 Feb 2018
Dividend Yield (%) 1.00
Book Value / Share () [*S] 169.40
P/B Ratio () [*S] 4.86
[*C] Consolidated     [*S] Standalone    

Natco Pharma Ltd - Financial Results

Particulars ( cr) Mar 2018 Mar 2017 % Chg
Net Sales 767.8 564.7 35.97
Other Income 20.1 -0.6 3450
Total Income 787.9 564.1 39.67
Total Expenses 384.5 323.6 18.82
Operating Profit 403.4 240.5 67.73
Net Profit 299.7 176.4 69.9
Equity Capital 36.9 34.9 -
> More on Natco Pharma Ltd Financials Results

Natco Pharma Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Alkem Lab 1959.15 0.07 23421.64
Glenmark Pharma. 590.35 0.73 16659.68
Abbott India 7155.35 3.49 15205.12
Natco Pharma 822.45 -1.16 15174.20
Pfizer 2630.15 1.48 12032.94
Sanofi India 5216.90 0.64 12014.52
Syngene Intl. 595.10 -0.97 11902.00
> More on Natco Pharma Ltd Peer Group

Natco Pharma Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 48.37
Banks/FIs 0.40
FIIs 23.96
Insurance 0.00
Mutual Funds 5.67
Indian Public 17.76
Custodians 0.00
Other 3.59
> More on Natco Pharma Ltd Share Holding Pattern

Natco Pharma Ltd - Research Reports

Date Broker Action Price Report
07/11 Equirus Securities Accumulate 957 PDF IconDetails
> More on Natco Pharma Ltd Research Reports

Natco Pharma Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week 3.12% 3.06% -0.54% -0.78%
1 Month 5.83% 4.98% 2.01% 1.66%
3 Month 5.68% 5.31% 7.73% 6.40%
6 Month -16.55% -16.91% 5.24% 3.14%
1 Year -15.15% -15.27% 13.58% 11.59%
3 Year 87.58% 87.62% 30.13% 30.97%

Natco Pharma Ltd - STOCK STRENGTH

Today's Low/High 816.00
841.70
Week Low/High 787.45
841.70
Month Low/High 735.00
841.70
YEAR Low/High 671.25
1062.00
All TIME Low/High 1.60
1080.00